SHANGHAI, March 13, 2025 /PRNewswire/ — BioCity Biopharmaceutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced that it has entered into a clinical trial collaboration agreement with MSD (Merck & Co., Inc., Rahway, NJ, USA), to […]
Tag: Clinical Trials & Medical Discoveries
Shilpa Medicare sichert sich SEC-CDSCO Nod für Nor-Ursodeoxycholsäure-Tabletten und strebt Markteinführung für NASH an
RAICHUR, Indien, 13. März 2025 /PRNewswire/ — Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), ein führender Hersteller von Wirkstoffen und Formulierungen, gibt bekannt, dass der Sachverständigenausschuss (SEC) der CDSCO sein neues Prüfpräparat (Investigational New Drug, IND) […]
GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T‑Cell Lymphoma CD5 CAR-NK Therapy
YONGIN, South Korea, March 12, 2025 /PRNewswire/ — GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB‑205), a novel CD5 […]
CONSUMING TREE NUTS AS SNACKS COULD AID IN PREVENTING THE DEVELOPMENT OF EXCESS BODY FAT AND CARDIOMETABOLIC DISEASE IN MILLENIALS
New Findings Published in Clinical Nutrition in Partnership with The International Tree Nut Council Nutrition Research & Education Foundation DAVIS, Calif., March 12, 2025 /PRNewswire/ — In a recent study published online in the journal, […]
Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASH
RAICHUR, India , March 12, 2025 /PRNewswire/ — Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved its Investigational New Drug (IND) […]
